"愛知県名古屋「 医療法人偕行会 名古屋共立病院 」 偕行会グループの基幹病院として地域の専門特化した高機能病院を目指し、がんの診断・治療に力を注いでいます。 病床数 156床（一般病床111床、地域包括ケア病床45床）、透析室18床 診療科目 内科、外科、整形外科、リウマチ科、神経内科、消化器内科、循環器内科、呼吸器内科、心臓血管外科、リハビリテーション科、 放射線科、腎臓内科、糖尿病内科、消化器外科、麻酔科、脳神経外科、形成外科、血管外科、病理診断科 1972年の開院以来、透析医療を中心に地域医療を守ってきました。 中でも透析患者様に対する合併症対策には力を入れ、複数の診療科が連携し治療にあたっています。 また、原因不明のふるえ「本態性振戦」に対する新治療「集束超音波治療（FUS）」を中部地区で初導入したほか、ガンマナイフやノバリスといった定位放射線治療機器を積極的に導入。新しい治療にも積極的に取り組んでいます。 そのほか、MRIやCTなど各種検査機器が充実しており、診療状況によっては待ち時間が少なく検査を受けていただくことも可能です。 名古屋共立病院は、地域の皆様と育んだ信頼関係と確かな技術でこれからも患者様の治療にあたってまいります。"

During the past decade, Nagoya Kyoritsu Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagoya Kyoritsu Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nagoya Kyoritsu Hospital" are "Central Nervous System Diseases" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diagnostic Imaging" (1 trials), "Heart Failure" (1 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "Nagoya Kyoritsu Hospital" in a lesser frequency.

Most popular intervention types in "Nagoya Kyoritsu Hospital" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "BI 690517" (1 trials), "Empa + lina highdose placebo" (1 trials), "Empagliflozin + linagliptin high dose" (1 trials) and "Empagliflozin + linagliptin low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagoya Kyoritsu Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nagoya Kyoritsu Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nagoya Kyoritsu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nagoya Kyoritsu Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".